Pathophysiology of functional mutations of the thiazide-sensitive Na-Cl cotransporter in Gitelman disease.
Most of the missense mutations that have been described in the human SLC12A3 gene encoding the thiazide-sensitive Na(+)-Cl(-) cotransporter (TSC, NCC, or NCCT), as the cause of Gitelman disease, block TSC function by interfering with normal protein processing and glycosylation. However, some mutations exhibit considerable activity. To investigate the pathogenesis of Gitelman disease mediated by such mutations and to gain insights into structure-function relationships on the cotransporter, five functional disease mutations were introduced into mouse TSC cDNA, and their expression was determined in Xenopus laevis oocytes. Western blot analysis revealed immunoreactive bands in all mutant TSCs that were undistinguishable from wild-type TSC. The activity profile was: wild-type TSC (100%) > G627V (66%) > R935Q (36%) = V995M (32%) > G610S (12%) > A585V (6%). Ion transport kinetics in all mutant clones were similar to wild-type TSC, except in G627V, in which a small but significant increase in affinity for extracellular Cl(-) was observed. In addition, G627V and G610S exhibited a small increase in metolazone affinity. The surface expression of wild-type and mutant TSCs was performed by laser-scanning confocal microscopy. All mutants exhibited a significant reduction in surface expression compared with wild-type TSC, with a profile similar to that observed in functional expression analysis. Our data show that biochemical and functional properties of the mutant TSCs are similar to wild-type TSC but that the surface expression is reduced, suggesting that these mutations impair the insertion of a functional protein into the plasma membrane. The small increase in Cl(-) and thiazide affinity in G610S and G627V suggests that the beginning of the COOH-terminal domain could be implicated in defining kinetic properties.
Sabath
Ernesto
E
Molecular Physiology Unit, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Instituto de Investigaciones Biomédicas, Universidad Nacional Autónoma de México, Tlalpan 14000, Mexico City, Mexico.
Meade
Patricia
P
Berkman
Jennifer
J
de los Heros
Paola
P
Moreno
Erika
E
Bobadilla
Norma A
NA
Vázquez
Norma
N
Ellison
David H
DH
Gamba
Gerardo
G
D000471:Alkalosis / Q000235:genetics*; D000818:Animals; D002352:Carrier Proteins / Q000235:genetics*; D004232:Diuretics / Q000008:administration & dosage; D004305:Dose-Response Relationship, Drug; D005260:Female; D006801:Humans; D007008:Hypokalemia / Q000235:genetics*; D017136:Ion Transport; D007674:Kidney Diseases / Q000235:genetics*; D007700:Kinetics; D008275:Magnesium Deficiency / Q000097:blood* / Q000235:genetics*; D008788:Metolazone / Q000008:administration & dosage; D051379:Mice; D016297:Mutagenesis, Site-Directed; D020125:Mutation, Missense; D009865:Oocytes; D011955:Receptors, Drug / Q000235:genetics*; D012964:Sodium / Q000493:pharmacokinetics; D049992:Sodium Chloride Symporters; D064486:Solute Carrier Family 12, Member 3; D027981:Symporters; D013577:Syndrome; D014982:Xenopus laevis
D002352:Carrier Proteins; D004232:Diuretics; D011955:Receptors, Drug; C578874:SLC12A3 protein, human; C578875:Slc12a3 protein, mouse; D049992:Sodium Chloride Symporters; D064486:Solute Carrier Family 12, Member 3; D027981:Symporters; C064415:thiazide receptor; D012964:Sodium; D008788:Metolazone